CELEX: 62007TB0169
Language: en
Date: 2008-12-02 00:00:00
Title: Case T-169/07: Order of the Court of First Instance of 2 December 2008 — Longevity Health Products v OHIM — Hennig Arzneimittel (Cellutrim) (Community trade mark — Invalidity proceedings — Community word mark Cellutrim — Earlier national word mark Cellidrin — Likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 40/94 — Action in part manifestly inadmissible and in part manifestly lacking any foundation in law)

21.2.2009   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 44/46
            
         Order of the Court of First Instance of 2 December 2008 — Longevity Health Products v OHIM — Hennig Arzneimittel (Cellutrim)
   (Case T-169/07) (1)
   
   (Community trade mark - Invalidity proceedings - Community word mark Cellutrim - Earlier national word mark Cellidrin - Likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 40/94 - Action in part manifestly inadmissible and in part manifestly lacking any foundation in law)
   (2009/C 44/81)
   Language of the case: German
   Parties
   
      Applicant: Longevity Health Products, Inc. (Nassau, Bahamas) (represented by: J. Korab, lawyer)
   
      Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: G. Schneider, acting as Agent)
   
      Other party to the proceedings before the Board of Appeal of OHIM intervening before the Court of First Instance: Hennig Arzneimittel GmbH & Co. KG (Flörsheim, Germany) (represented by: S. Ziegler, C. Kleiner and F. Dehn, lawyers)
   Re:
   Action brought against the decision of the First Board of Appeal of OHIM of 7 March 2007 (Case R 1123/2006-1) concerning invalidity proceedings between, initially, Celltech Pharma GmbH & Co. KG and, subsequently, Hennig Arzneimittel GmbH & Co. KG and Longevity Health Products, Inc.
   Operative part of the order
   
               1.
            
            
               The action is dismissed.
            
         
               2.
            
            
               Longevity Health Products, Inc. is ordered to pay the costs.
            
         
      (1)  OJ C 155, 7.7.2007.